BMRN vs PLRX · P/E 40, rev $1.76B vs $77.3M cap
Biomarin Pharmaceutical Inc (BMRN) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported PLRX revenue for 2025-12-31 was $0. Net income was -$149.3M. PLRX currently screens at market cap $77.3M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. PLRX currently screens at market cap $77.3M.
Not investment advice. Open the BMRN and PLRX stock pages for the full models.
Not investment advice.